Pages that link to "Q423366"
Jump to navigation
Jump to search
The following pages link to nelfinavir (Q423366):
Displayed 50 items.
- HIV/AIDS (Q12199) (← links)
- irinotecan (Q412197) (← links)
- lovastatin (Q417740) (← links)
- ergotamine (Q419186) (← links)
- dihydroergotamine (Q421336) (← links)
- methylergonovine (Q424477) (← links)
- simvastatin (Q670131) (← links)
- human immunodeficiency virus infectious disease (Q18556697) (← links)
- (Q3874410) (redirect page) (← links)
- Circulating metabolites of the human immunodeficiency virus protease inhibitor nelfinavir in humans: structural identification, levels in plasma, and antiviral activities (Q24550608) (← links)
- Effect of rifampin and nelfinavir on the metabolism of methadone and buprenorphine in primary cultures of human hepatocytes (Q24649164) (← links)
- (3S,4aR,8aR)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide (Q27166487) (← links)
- New insights into the in silico prediction of HIV protease resistance to nelfinavir (Q27324517) (← links)
- Molecular analysis of the HIV-1 resistance development: enzymatic activities, crystal structures, and thermodynamics of nelfinavir-resistant HIV protease mutants (Q27648939) (← links)
- Resistance mechanism revealed by crystal structures of unliganded nelfinavir-resistant HIV-1 protease non-active site mutants N88D and N88S (Q27657249) (← links)
- HIV-1 Protease-Substrate Coevolution in Nelfinavir Resistance (Q27683192) (← links)
- Structural Basis of Why Nelfinavir-Resistant D30N Mutant of HIV-1 Protease Remains Susceptible to Saquinavir (Q27696689) (← links)
- Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease (Q27748305) (← links)
- Nelfinavir and other protease inhibitors in cancer: mechanisms involved in anticancer activity (Q28083142) (← links)
- Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from patients treated with the protease inhibitor nelfinavir. (Q28369030) (← links)
- Symptomatic junctional bradycardia after treatment with nelfinavir (Q28372260) (← links)
- A randomized, comparative study of lamivudine plus stavudine, with indinavir or nelfinavir, in treatment-experienced HIV-infected patients (Q28372784) (← links)
- A generalized seizure following initiation of nelfinavir in a patient with human immunodeficiency virus type 1 infection, suspected due to interaction between nelfinavir and phenytoin (Q28376604) (← links)
- Activities of the human immunodeficiency virus type 1 (HIV-1) protease inhibitor nelfinavir mesylate in combination with reverse transcriptase and protease inhibitors against acute HIV-1 infection in vitro (Q28379173) (← links)
- Nelfinavir, an HIV-1 protease inhibitor, induces oxidative stress-mediated, caspase-independent apoptosis in Leishmania amastigotes (Q28473470) (← links)
- Drug discovery using chemical systems biology: weak inhibition of multiple kinases may contribute to the anti-cancer effect of nelfinavir (Q28477930) (← links)
- Subverting ER-stress towards apoptosis by nelfinavir and curcumin coexposure augments docetaxel efficacy in castration resistant prostate cancer cells (Q28541919) (← links)
- Oxidative Stress Mediates the Antiproliferative Effects of Nelfinavir in Breast Cancer Cells (Q28550200) (← links)
- Viracept (Q29006653) (← links)
- Cycloviolacin O2 (CyO2) suppresses productive infection and augments the antiviral efficacy of nelfinavir in HIV-1 infected monocytic cells. (Q30352465) (← links)
- Protective effects of alanyl-glutamine supplementation against nelfinavir-induced epithelial impairment in IEC-6 cells and in mouse intestinal mucosa (Q30415997) (← links)
- Novel synthesis and spectral characterization of nelfinavir (Q31153074) (← links)
- Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: potential drug interactions with bupropion (Q31835702) (← links)
- Efficacy, tolerance, and pharmacokinetics of the combination of stavudine, nevirapine, nelfinavir, and saquinavir as salvage regimen after ritonavir or indinavir failure (Q31934005) (← links)
- Phenotypic cross-resistance to nelfinavir: the role of prior antiretroviral therapy and the number of mutations in the protease gene (Q31934121) (← links)
- Sensitive and rapid method for the simultaneous quantification of the HIV-protease inhibitors indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by reversed-phase liquid chromatography (Q32018568) (← links)
- Significant decrease in nelfinavir systemic exposure after omeprazole coadministration in healthy subjects (Q33155841) (← links)
- The HIV protease inhibitor nelfinavir induces insulin resistance and increases basal lipolysis in 3T3-L1 adipocytes (Q33182048) (← links)
- Simultaneous determination of six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir), the active metabolite of nelfinavir (M8) and non-nucleoside reverse transcriptase inhibitor (efavirenz) in human plas (Q33217633) (← links)
- Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study (Q33237758) (← links)
- Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children (Q33249816) (← links)
- Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir (Q33321331) (← links)
- Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir (Q33431825) (← links)
- Safety, pharmacokinetics, and antiretroviral activity of the potent, specific human immunodeficiency virus protease inhibitor nelfinavir: results of a phase I/II trial and extended follow-up in patients infected with human immunodeficiency virus (Q33487821) (← links)
- HIV protease inhibitors, indinavir or nelfinavir, augment antimalarial action of artemisinin in vitro (Q33578923) (← links)
- Nelfinavir mesylate: a protease inhibitor (Q33592439) (← links)
- Nelfinavir inhibits maturation and export of herpes simplex virus 1. (Q33602791) (← links)
- Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and prevention (Q33642284) (← links)
- Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscape (Q33648513) (← links)
- Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353. (Q33705707) (← links)